Lennar, Darden Restaurants, Novavax Fall Premarket; Eli Lilly, H.B. Fuller Rise

  • Investing.com
  • Stock Market News
Lennar, Darden Restaurants, Novavax Fall Premarket; Eli Lilly, H.B. Fuller Rise

By Peter Nurse

Investing.com -- Stocks in focus in premarket trade on Thursday, September 22nd. Please refresh for updates.

  • Lennar (NYSE: LEN ) stock fell 1.5% after the homebuilder reported better-than-expected third-quarter results , boosted by record high prices, but new home sales disappointed.

  • Darden Restaurants (NYSE: DRI ) stock fell 3.3% after the Olive Garden owner said same-restaurant sales rose by 4.2% on the quarter, below expectations.
  • H.B. Fuller (NYSE: FUL ) stock rose 2.2% after the adhesives company beat quarterly earnings expectations, citing “robust pricing actions to recover unprecedented raw material cost inflation.”

  • Accenture (NYSE: ACN ) stock fell 0.3% after the IT services firm forecast first-quarter revenue below expectations, weighed down by IT spending cuts amid high inflation and impact from a stronger dollar .

  • Eli Lilly (NYSE: LLY ) stock rose 1.8% after UBS upgraded its investment stance on the pharma company to ‘buy’ from ‘neutral’, citing the likely benefits of futures sales of a key weight loss drug.

  • Salesforce (NYSE: CRM ) stock rose 2.5% after the cloud-based software company announced plans for a 25% operating margin by 2026, seeking to operate much more efficiently.

  • Target (NYSE: TGT ) stock rose 0.2% after the big-box retailer announced plans to hire up to 100,000 seasonal workers for the holiday season and start offering festive deals earlier than ever.

  • Manchester United (NYSE: MANU ) stock will be in focus after the English soccer club reported a net loss of 70.7 million pounds for the three months to June 30, a narrowing from a loss of 107.7 million pounds a year earlier.

  • Nike (NYSE: NKE ) stock rose 0.7% after RBC initiated coverage of the retailer at ‘outperform’, saying the “100lb gorilla in sportswear” is set to surge almost 30%.

  • Novavax (NASDAQ: NVAX ) stock fell 5.7% after JPMorgan downgraded its stance on the drug maker to 'underweight' from 'neutral'. citing reduced vaccine demand.

Drop an image here or Supported formats: *.jpg, *.png, *.gif up to 5mb

Error: File type not supported

Drop an image here or


Related Articles